Yanna Ko

Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific

Siew C. Ng, Whitney Tang, Rupert W. Leong et al. · Gut · 2014 · 440 citations · Full text

Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case–Control Study of Middle Eastern Migration to Australia

Yanna Ko, Viraj C. Kariyawasam, Mohamad Karnib et al. · Clinical Gastroenterology and Hepatology · 2015 · 77 citations

Population Exposure, Environmental Health, Gastroenterology +8

Superior treatment persistence with ustekinumab in Crohn’s disease and vedolizumab in ulcerative colitis compared with anti‐TNF biological agents: real‐world registry data from the Persistence Australian National IBD Cohort (PANIC) study

Yanna Ko, Sudarshan Paramsothy, Yunki Yau et al. · Alimentary Pharmacology & Therapeutics · 2021 · 75 citations

Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitis

Rupert W. Leong, Tony Huang, Yanna Ko et al. · Journal of Crohn s and Colitis · 2014 · 60 citations

Vedolizumab has longer persistence than infliximab as a first-line biological agent but not as a second-line biological agent in moderate-to-severe ulcerative colitis: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study

Aviv Pudipeddi, Yanna Ko, Sudarshan Paramsothy et al. · Therapeutic Advances in Gastroenterology · 2022 · 35 citations · Full text